Showing 2511-2520 of 3547 results for "".
DermWireTV: GlobalSkin, ILDS Collab; New approach with Tafinlar; Equity in Telehealth; Dupixent pen
https://practicaldermatology.com/topics/practice-management/dermwiretv-globalskin-ilds-collab-new-approach-with-tafinlar-equity-in-telehealth-dupixent-pen/19952/A data analysis presented at the 2021 American Society of Clinical Oncology Annual Meeting shows that a new approach to managing fevers associated with dabrafenib increases treatment tolerability and avoids discontinuation of therapy. Global Skin (International Alliance of Dermatology Patient OrganiRhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyHow Air Pollution Affects the Skin
https://practicaldermatology.com/programs/practical-dermatology/how-air-pollution-affects-the-skin/24041/An Interview with Dr. Mark Birch-MachinStaying Ahead of the Curve
https://practicaldermatology.com/topics/practice-management/staying-ahead-of-the-curve/20882/Is your practice website responsive enough?Psoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/psoriasis-biologics-and-cardiovascular-disease-the-heart-of-the-matter/23215/A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-39/23790/The Hidradenitis Suppurativa Therapeutic Pipeline
https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.Exploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.Mycosis Fungoides: Diagnosis and Work-up of Early Stage Disease
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-diagnosis-and-work-up-of-early-stage-disease/22004/The ability to differentiate MF from mimickers permits early diagnosis and treatment, potentially improving long-term outcomes.Top 10 Ways to Improve Acne Treatment
https://practicaldermatology.com/topics/practice-management/top-10-ways-to-improve-acne-treatment/21151/Tips for enhancing treatment regimens for better results.